Document is current
Any future updates will be listed below
-
Authors
Fazio, Nicola https://orcid.org/0000-0001-6869-0704
Falconi, Massimo https://orcid.org/0000-0001-9654-7243
Foglia, Emanuela https://orcid.org/0000-0003-1381-9069
Bartolomei, Mirco https://orcid.org/0000-0002-6474-4143
Berruti, Alfredo https://orcid.org/0000-0002-3956-0043
D’Onofrio, Mirko https://orcid.org/0000-0003-3229-9329
Ferone, Diego https://orcid.org/0000-0002-1410-6143
Giordano, Alessandro https://orcid.org/0000-0002-6978-0880
Grimaldi, Franco https://orcid.org/0000-0002-7527-8010
Milione, Massimo https://orcid.org/0000-0002-1202-139X
Panzuto, Francesco https://orcid.org/0000-0003-2789-4289
Santimaria, Monica https://orcid.org/0000-0002-2261-2230
Schillaci, Orazio https://orcid.org/0000-0002-6176-2805
Seregni, Ettore https://orcid.org/0000-0002-5097-049X
Stasi, Michele https://orcid.org/0000-0003-1294-0967
Volante, Marco https://orcid.org/0000-0003-0719-105X
Lastoria, Secondo https://orcid.org/0000-0002-6649-9903
-
Funding
Funding for this research was provided by:
Sentrix/VMLY&Rx
- License Information
-
More Information
Article History
Received: 24 July 2023
Accepted: 17 October 2023
First Online: 21 November 2023
Declarations
:
: Nicola Fazio has received fees for public speaking and advisory board activities from Novartis, Advanced Accelerator Applications, Ipsen, Sanofi, Hutchmed, Merck and MSD. Mirco Bartolomei has received fees for advisory board activities from Advanced Accelerator Applications. Diego Ferone has received fees for public speaking and advisory board activities from Advanced Accelerator Applications, Ipsen, Sandoz, Recordati and Camurus. Emanuela Foglia has received educational grants and advisory boards fees from Advanced Accelerator Applications, Ethicon, Astellas Pharma and Werfen—Instrumentation Laboratories. Franco Grimaldi has received fees from Advanced Accelerator Applications, Novo Nordisk, Boehringer Ingelheim, Ipsen, Merck, Eisai and Roche. Marco Volante has received fees for advisory board activities from Advanced Accelerator Applications. Secondo Lastoria has received fees for advisory board activities from Advanced Accelerator Applications. Massimo Falconi, Alfredo Berruti, Mirko D’Onofrio, Alessandro Giordano, Massimo Milione, Francesco Panzuto, Monica Santimaria, Orazio Schillaci, Ettore Seregni, and Michele Stasi declare that they have no competing interests.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.
